A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization

NCT01157455 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1900

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Diseases

Interventions

PROCEDURE: Everolimus Drug Eluting Stent
DRUG: Aspirin
DRUG: Clopidogrel
DRUG: Heparin or Bivalirudin

Sponsor

CCRF Consulting Co., Ltd.